Año: 2020
Journal Impact Factor (JIF): 10.3380
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
CLINICAL NEUROLOGY | SCIE | 10/208 | Q1 | T1 | D1 |
Año: 2020
Journal Citation Indicator (JCI): 2,390
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
CLINICAL NEUROLOGY | 11/255 | Q1 | T1 | D1 | 95,88 |
Año:
2020
CiteScore:
13,300
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Neurology | 4/156 | Q1 | T1 | D1 |
Neurology (clinical) | 12/343 | Q1 | T1 | D1 |
SJR año:
2020
Factor de Impacto:
3,352
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Neurology | 4/185 | Q1 | T1 | D1 |
Neurology (clinical) | 14/403 | Q1 | T1 | D1 |
Agencia | Código de Proyecto |
---|---|
AbbVie | - |
Allergan | - |
Avid Radiopharmaceuticals | - |
Biogen | - |
BioLegend | - |
Bristol-Myers Squibb | - |
Celgene | - |
Denali Incorporated | - |
Eli Lilly and Company | - |
GE Healthcare | - |
Genentech | - |
GlaxoSmithKline | - |
Golub Capital | - |
Intramural Research Program of the National Institute on Aging, National Institutes of Health, Department of Health and Human Services | ZO1 AG000949 |
Lundbeck | - |
Merck Co. | - |
Meso Scale Discovery | - |
Michael J. Fox Foundation | - |
Michael J. Fox Foundation for Parkinson's research | - |
MRC | MR/L023784/2; MR/T04604X/1; UKDRI-3003 |
Pfizer | - |
Piramal | - |
Prevail Therapeutics | - |
Roche | - |
Sanofi Genzyme | - |
Servier Laboratories | - |
Takeda | - |
Teva | - |
UCB | - |
Verily | - |
Voyager Therapeutics | - |
# | Autor |
---|---|
1 | Iwaki, H. |
2 | Blauwendraat, C. |
3 | Makarious, M. B. |
4 | Bandres-Ciga, S. |
5 | Leonard, H. L. |
6 | Gibbs, J. R. |
7 | Hernández, D. G. |
8 | Scholz, S. W. |
9 | Faghri, F. |
10 | Nalls, M. A. |
11 | |
# | Autoría grupal |
1 | Labrador-Espinosa, Miguel A. (International Parkinson's Disease Genomics Consortium [IPDGC]) |
2 | Mir, Pablo (International Parkinson's Disease Genomics Consortium [IPDGC]) |
3 | Periñán-Tocino, Teresa (International Parkinson's Disease Genomics Consortium [IPDGC]) |